| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | 1.1% | $3,340 | 73,892 | AstraZeneca PLC | 31 Mar 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$904 | $0.05 | 0 |
| 2025 Q1 | 20,000 | $904 | -$596,595 | $0.05 | 1 |
| 2024 Q4 | 8,729,799 | $598,578 | +$318,659 | $0.07 | 38 |
| 2024 Q3 | 4,047,175 | $479,704 | -$31,364 | $0.12 | 32 |
| 2024 Q2 | 2,915,519 | $3,091,156 | +$1,222,334 | $1.06 | 28 |
| 2024 Q1 | 1,611,148 | $5,914,895 | +$808,610 | $3.67 | 17 |
| 2023 Q4 | 1,375,057 | $6,263,930 | +$6,232,093 | $4.55 | 11 |
| 2023 Q3 | 5,353 | $32,002 | +$32,002 | $5.97 | 3 |